diac abnormalities do occur following BMT in childhood and thus, there is a clear need for continued, serial long-term cardiac evaluation in transplant survivors. Sixty-three patients who had undergone a BMT at age р18 years were evaluated cross-sectionally to determine Evaluations should include exercise stress testing to detect inadequate cardiac output as well as oxygen concardiac function as well as the long-term prevalence, types, severity, and risk factors of cardiac abnormalisumption during exercise. Keywords: cardiac; bone marrow transplant ties. Patients were у1 year post-BMT and were evaluated by history, resting ECG, echocardiography (ECHO), exercise treadmill test, chest X-ray, pulmonary function tests and review of past cardiac studies.
). Patients' ages
row transplant as part of their therapy, and the success of ranged from 1.9 to 32 years (median 10.9 years) with marrow transplantation has continued to improve since the median follow-up of 3.3 years (range 1-16.3 years).
early 1970s. Thus with an increasing number of survivors, Twenty-six patients (41.3%) had a cardiac abnormality it will be important to place more emphasis on the longdetected at follow-up. In 21 patients the abnormal findterm adverse effects that may occur in transplant patients, ing had not been present at the pre-BMT evaluation.
including effects on cardiac function. Ten patients (16.4%) had resting ECG abnormalities.
There are many different mechanisms of potential Left ventricular ejection fraction (LVEF) by ECHO was impairment of myocardial function in the transplant setting mildly decreased to 50-54% in three patients and markincluding the preparative regimens of high-dose cyclophosedly decreased to 40% in one patient. Only one patient phamide given with total body irradiation (TBI) or with (1.7%) developed a mildly abnormal shortening fraction other chemotherapeutics, 2-6 electrolyte abnormalities, and of 27%. All patients with ECHO abnormalities were sepsis. 7, 8 Previous anthracycline, 9-11 cyclophosphamide or asymptomatic. Twenty-three of 31 patients у9 years of radiation therapy 12-14 may also potentiate problems. Findage (74%) who underwent a treadmill exercise test had ings can include nonspecific electrocardiographic (ECG) a borderline or abnormal response to exercise. There changes as well as total QRS voltage decrease, arrhythmias, was no correlation between demographic factors, prepericardial disease, valvular disease, asymptomatic vious therapy, preparative regimen or length of followdecreased left ventricular fractional shortening, clinically up with the post-BMT ECG, ECHO and treadmill significant congestive heart failure, and fatal cardiomyoabnormalities. Overall, eight patients (12.7%) were pathy. symptomatic and NYHA class II or III, and all had Currently, most reports on cardiac complications in the abnormal exercise tests. The presence of symptoms and BMT setting have concerned either short-term toxicity or NYHA class were predictors for oxygen consumption have been restricted to adult patients. [15] [16] [17] [18] Consequently, the during exercise (P = 0.03 and 0.02, respectively) and frequency and significance of late cardiac abnormalities are tended to predict overall treadmill results also. Late carunknown, especially among patients undergoing BMT in childhood. To define further the extent of cardiac effects in children undergoing bone marrow transplant and to deter- (n = 17) had a current or past history of chronic GVHD. The median follow-up after transplantation was 3.3 years (range 1-16.3 years). the entire cohort) and mean length of time post-BMT (4.1 years vs 7.3 years). Our study population also had a higher The study population did not differ from the non-participants who had scheduled return follow-up visits by age, percentage of unrelated donor (URD) transplant patients (22% vs 13%) and a higher incidence of acute GVHD (49% sex, type of BMT, age at BMT, or time from transplant. However, there was a higher proportion of acute lymphovs 31%). blastic leukemia patients in the study group and more aplastic anemia patients in the non-participant group; both these Cardiac evaluation methods differences reached statistical significance. Also, the nonparticipants received a statistically significant lower mean At the time of their follow-up clinic visit, a brief questionnaire was administered regarding activity level, exercise TBI dose (1152 cGY vs 861 cGY). We also assessed differences between our study population and the entire cohort tolerance, and the presence of any symptoms such as chest pain, palpitations, syncope, shortness of breath, and easy of surviving BMT patients who met our eligibility criteria (Table 1 ). Significant differences were observed for mean fatigability. Based on this questionnaire, each patient was assigned a New York Heart Association (NYHA) classicurrent age (11.7 years in the study group vs 15.8 years in fication with class I defined as unlimited activity without All patients had a chest X-ray, 12-lead resting ECG and either an ECHO or radionuclide cardiac angiography persymptoms, class II when ordinary physical activity causes symptoms, class III having marked limitation of activity formed within 1 month prior to BMT. These results were compared to those of the same patient at the time of longdue to symptoms but no symptoms at rest, and finally, class IV defined as any activity causes symptoms and symptoms term follow-up. All studies were carried out in accordance with the may occur at rest.
A 12-lead resting ECG was recorded on 61 patients at a guidelines of the University of Minnesota Institutional Review Board Committee on the Use of Human Subjects speed of 50 mm/s using quality-controlled devices. Chest X-rays done at the time of follow-up were available for 53 in Research. patients and were read by a radiologist who was not aware of the results of the cardiac studies.
Statistical analysis Each patient underwent echocardiography (ECHO) at the time of follow-up using a Hewlett Packard 1000 (Hewlett The characteristics of the study population were compared Packard, Sunnyvale, CA, USA) with 2.5, 3.75 and 5 MHz to returning patients who did not participate as well as to transducers and a standard ECG lead. Two-dimensional the entire pediatric BMT cohort of survivors using tworecordings were performed from parasternal, apical, subcosample t-tests. The potential effects of sex, age, diagnosis, stal and suprasternal notch windows and an estimated sinprevious therapy including anthracyclines, age at BMT, gle plane left ventricular ejection fraction (LVEF) was type of BMT, preparative regimen, GVHD and length of determined. The LVEF was considered normal if у55%, follow-up on the post-BMT cardiac studies were examined mildly abnormal if 50-54%, moderately abnormal if 40-using univariate anlaysis with 2 test and logistic 49% and severely abnormal if Ͻ40%. Color flow and specregression. Factors that were found to be significant or tral Doppler cardiography was performed for the qualitinearly so (P Ͻ 0.10) were subjected to multivariate analyative and quantitative assessment of blood flow and valvuses using stepwise logistic regression for categorical depenlar sufficiency. M-mode recordings directed by twodent variables and multiple linear regression for continuous dimensional echocardiography were obtained using a variables. All P values are two-sided and considered to be 50 mm/s strip chart recorder. The left ventricle internal statistically significant if P Ͻ 0.05. dimension at both end systole and end diastole were measured according to the recommendations of the American Society of Echocardiography 19 and allowed the calculation of the shortening fraction (SF). The SF was considered norResults mal if у29%, mildly abnormal if 25-28%, moderately abnormal if 21-24%, and severely abnormal if р20%.
Overall, 26 patients (41.3%) had a cardiac abnormality Thirty-one patients (49%) who were at least 9 years of detected at the time of follow-up, and in 21 patients this age and physically able underwent a treadmill exercise test finding had not been present at the pre-BMT evaluation. as per a standard Bruce progressive continuous exercise Eleven patients had previous ECG abnormalities prior to protocol with ECG monitoring and manual blood pressure transplant that were not apparent at the time of follow-up. measurements. 20 Twenty-five patients (40%) who were Eight patients had a mild (49-54%) decrease in their LVEF under 9 years of age were not considered for treadmill testjust prior to transplant which had normalized by the time ing, two patients were physically unable, and five had a of follow-up. schedule conflict precluding time for the test. The following parameters of exercise performance and response were assessed during the treadmill test: endurance time, heart Questionnaire rate response, systolic blood pressure (SBP) response, peak double product (maximal heart rate multiplied by maximal Completed questionnaires regarding activity level, exercise tolerance, and cardiac-related symptoms were available for SBP), maximum oxygen consumption, exercise ECG, symptoms and reason for termination. Exercise perform-62 patients (Table 2) . At the time of follow-up eight patients (12.7%) were symptomatic, including shortness of ance was expressed as a percentage of normal according to published standards for age and sex. 21 The heart rate breath (n = 7), easy fatigability (n = 4), chest pain (n = 3) or palpitations (n = 1). Six patients had symptoms with response was considered normal if the % predicted maximal heart rate for age and sex at peak exercise was у85%, ordinary physical activity (NYHA class II) and two had marked limitation of their activity due to symptoms borderline if 80-84% and abnormal if Ͻ80%. The SBP response was considered normal if SBP at peak exercise (NYHA class III). There were no cases of congestive heart failure or clinically significant cardiomyopathy in our study had increased by у30 mm Hg, borderline if increased 25-29 mm Hg, and abnormal if increased Ͻ25 mm Hg. The population at the time of follow-up. All patients with ECHO abnormalities at the time of study were asymptomoxygen consumption during exercise as estimated from the endurance time was stated as the % predicted maximal O 2 atic. The self-report of symptoms as well as the assigned NYHA class did tend to predict overall exercise tolerance uptake for age and sex and was considered normal if у80%, borderline if 70-79%, and abnormal if Ͻ70%.
on the treadmill (P = 0.07 for both), and specifically, were found to be statistically significant predictors for oxygen Twenty-seven of the 31 patients undergoing treadmill testing had static pulmonary diffusion capacity and spirometry consumption during exercise (P = 0.03 and 0.024, respectively). evaluated as well. Table 2 Cardiac findings
Treadmill exercise test
Exercise tests were performed on 31 (86%) of 36 patients
No.
who were at least 9 years of age and physically able. Overall, 74% were determined to have an inadequate response to
exercise by one or more parameters ( treadmill test parameters.
Discussion

Resting ECG
Bone marrow transplant is now widely used to treat both Sixty-one patients had 12-lead resting ECG recordings; of malignant and nonmalignant disorders in children. While these, 10 (16.4%) were read as abnormal. These findings most centers perform a thorough cardiac evaluation just included right atrial enlargement (RAE) (n = 3), right venprior to transplant, surprisingly little information is availtricular enlargement (n = 3), first degree AV block (n = 1), able regarding long-term cardiac function following large nonspecific ST-T wave changes (n = 1), conduction delay doses of chemotherapeutic agents as well as total-body (n = 1) and one patient had RAE, biventricular hypertrophy irradiation given to children during transplant. The goals and ST elevation. In the four patients with ventricular hypertrophy this abnormality was also present prior to transplant. A history of past or current chronic GVHD was Table 3 Treadmill exercise test results found to be the only risk factor for ECG abnormalities (P = 0.005). who had SF measured, 59 (98.3%) were normal at long-HR = heart rate; SBP = systolic blood pressure.
term follow-up with a median SF of 37.5 ± 4.8%.
of the present study were to determine cardiac function in post-transplant in the majority of patients. Another series of adult patients 15 revealed cardiac complications in 43% children who had undergone a BMT and to determine the extent of abnormalities as well as possible risk factors.
and a cardiac-specific mortality rate of 9% within 9 months following BMT, and the authors concluded that cardiac toxOverall, 41% (n = 26) of our series of 63 patients had a cardiac abnormality detected at a median follow-up of 3.3 icity is one of the most important limiting factors for BMT. However, both studies concern adult patients and shortyears. Thirteen percent (n = 8) of our sample was symptomatic at the time of follow-up, although there were no cases term toxicity. Just recently, Pihkala et al 26 reported one of the first studies regarding cardiac function in long-term of congestive heart failure or life-threatening cardiomyopathy. Importantly, of those 26 patients with abnormalities, childhood survivors of transplant. Late cardiotoxicity was evaluated in 30 patients with a median follow-up of 4.8 69% were subclinical at the time of follow-up.
The most significant finding in our study was the high years. A 13% incidence of left ventricular dysfunction was found on ECHO and 26% had a LVEF of Ͻ50% on radioprevalence of abnormalities on treadmill exercise testing. Our study is one of very few studies which have utilized nuclide cineangiography. In our study we found a lower prevalence of decreased exercise testing as part of the cardiac evaluation following BMT. However, our findings are similar to those reported ejection fraction on ECHO (8.5%), but as in the Pihkala study, all our patients with an abnormal ECHO were by Lipshultz et al 10 in which 48% of childhood leukemia patients who had received anthracyclines had an abnorasymptomatic at the time of follow-up. Most data regarding therapy with anthracyclines in children show that the likelimality on treadmill testing. Nearly 50% of their patients also had decreased contractility on ECHO; however, all hood of myocardial dysfunction is directly associated with the length of follow-up, and serious consequences can patients in our study with exercise test abnormalities had normal cardiac function by ECHO. The 30% who had an appear with few signs or symptoms. 9, 10 Since the median follow-up in the present study is 3.3 years, our patient inadequate increase in their SBP with exercise are of concern. This may indicate inadequate cardiac output in these population may not be representative of long-term survivors, and abnormalities may arise in some patients who patients when stressed as nearly all had exercised an adequate length of time and all had an adequate heart rate currently have none detected. Previous studies have shown that even asymptomatic patients who have received anthraincrease. A decrease in stroke volume secondary to subclinical cardiomyopathy could explain the abnormalities.
cyclines have myocardial structural damage on biopsy specimens. 27 Although it is not known if this is the case Oxygen consumption during treadmill testing was inadequate in 68%. Certainly there are a variety of mechanisms with high-dose cyclophosphamide or TBI in the transplant setting, sensitivity of detecting subclinical cardiotoxicity that can lead to decreased oxygen consumption during exercise, most important of which is primary pulmonary disease would be greatly enhanced by serial testing patients. Earlier studies regarding cardiac toxicity in BMT have after transplant. Previous studies 22, 23 have shown that both early and late pulmonary sequelae are not uncommon folalso suggested that previous therapy with anthracyclines increases the risk of toxicity following transplant. 11, 15 We lowing transplant, and up to 19% of children develop obstructive lung disease post-BMT. Also, the presence of did not find such an association in our study; however, the number of patients is too small for conclusive analysis of chronic GVHD has been found to be strongly associated with clinically significant obstructive lung disease and the effect of anthracyclines. We also found no association between detected abnormalities and the use of high-dose bronchiolitis obliterans. 23, 24 In the current study, seven (30%) of the 23 patients with an abnormal treadmill test cyclophosphamide in the preparative regimen. Fifty-four of our patients had received at least 120 mg/kg and only four had a history of chronic GVHD, and nine of 13 patients with clearly abnormal oxygen consumption had abnormal patients in our entire series had decreased contractility by ECHO at the time of long-term follow-up. In addition, the static pulmonary function tests. Certainly, chronic lung disease leading to cardiac damage can be very difficult to difmethod of TBI delivery, whether single, fractionated, or hyperfractionated, was not predictive of late cardiotoxicity. ferentiate from primary cardiomyopathy. Our study is also limited by the fact that oxygen consumption was not actuOnly 22% of the eligible survivors transplanted at our institution were evaluated in this study. Selection bias could ally measured, but instead, estimated from the endurance time. Other underlying factors that may contribute to poor lead to an overestimation of the prevalence of late cardiotoxicity as patients with ongoing medical problems may oxygen consumption during exercise include detraining or deconditioning, malnutrition, muscle atrophy and anemia.
be more likely to return for follow-up and be available to participate in the study. The majority of the baseline characHowever, of the 21 patients with abnormal oxygen consumption in our study, only three were mildly anemic (Hgb teristics of the patients who returned for follow-up but did not participate as well as the characteristics of the entire 11-11.5 g/dl). Although the other factors were not assessed in the current study, all may be potentially playing a role BMT survivor cohort did not differ from our study population. However, a higher proportion of our study to some extent, in children following transplant.
It has been over two decades since the first cases of carpatients had URD transplants, more chronic GVHD and less follow-up. diac toxicity in the transplant setting were reported. However, only recently have data regarding studies involving
We have shown that late cardiac abnormalities do occur after bone marrow transplantation in children, and thus, larger series of patients been available. In 1990, Kupari et al 25 
